The Influence of Hypothalamic Steroid Implants on Ovulation and Ovarian Growth and Function in the Iguanid Lizard, Sceleporus cyanogenys by McConnell, William F.
W&M ScholarWorks 
Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 
1970 
The Influence of Hypothalamic Steroid Implants on Ovulation and 
Ovarian Growth and Function in the Iguanid Lizard, Sceleporus 
cyanogenys 
William F. McConnell 
College of William & Mary - Arts & Sciences 
Follow this and additional works at: https://scholarworks.wm.edu/etd 
 Part of the Physiology Commons 
Recommended Citation 
McConnell, William F., "The Influence of Hypothalamic Steroid Implants on Ovulation and Ovarian Growth 
and Function in the Iguanid Lizard, Sceleporus cyanogenys" (1970). Dissertations, Theses, and Masters 
Projects. Paper 1539624685. 
https://dx.doi.org/doi:10.21220/s2-1smx-cy32 
This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M 
ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
THE INFLUENCE OF HYPOTHALAMIC STEROID IMPLANTS ON OVULATION 
AND OVARIAN GROWTH AND FUNCTION IN THE IGUANID LIZARD,
SCELOPORUS CYANOGENYS
A Thesis 
Presented to 
The Faculty of the Department of Biology 
The College of William and Mary in Virginia
In Partial Fulfillment 
Of the Requirements for the Degree of 
Master of Arts
By
William F. McConnell
1970
ProQ uest Number: 10625114
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction  is d e p e n d e n t  upon  th e  quality of th e  co p y  subm itted.
In th e  unlikely e v en t th a t th e  au thor did no t send  a  c o m p le te  m anuscript 
an d  th ere  a re  missing p a g e s , th e se  will b e  n o ted . Also, if m aterial h ad  to  b e  rem oved ,
a  n o te  will ind icate  th e  deletion.
uest
ProQ uest 10625114
Published by ProQ uest LLC (2017). Copyright of th e  Dissertation is held by th e  Author.
All rights reserved.
This work is p ro te c te d  against unauthorized copying under Title 17, United S tates C o d e
Microform Edition © ProQ uest LLC.
ProQ uest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
APPROVAL SHEET
This thesis is submitted in partial fulfillment of 
the requirements for the degree of 
Master of Arts
William F. McConnell
App roved, May 1970
/  /
Ian P. Callard, Ph.D.
Webster Van Winkle, Ph.D.
4L<UlU( v
Charlotte P. Mangum, Ph.D.
ACKNOWLEDGMENTS
The writer wishes to express his appreciation to Dr. Ian P. Callard 
whose continuing interest and constructive criticism were invaluable to 
the completion of this program.
The author would also like to thank Dr. Webster Van Winkle and Dr. 
Charlotte Mangum for constructive and critical editing of the manuscript. 
Appreciation is also extended to Mrs. Sharon Ziegel for her assistance 
in the analysis of plasma proteins.
Last, but by no means least, may I thank my wife for the many hours 
of work she contributed in all phases of the work, for her patience, and 
her support.
iii
TABLE OF CONTENTS
Page
ACKNOWLEDGMENTS ......     . ......  ill
LIST OF TABLES ............................................  v
ABSTRACT .....   ..........    vi
INTRODUCTION . . . .’ , .      2
MATERIALS AND METHODS .................    4
RESULTS .........         8
DISCUSSION .............................    21
BIBLIOGRAPHY ......    28
iv
LIST OF TABLES
Table Page
I. The Influence of Hormonal Implants on
Ovulation in Sceloporus cyanogenys .......   14
II. Ovarian and Oviduct Weights from Pre- and
Postovulatory Sceloporus cyanogenys, Series 1 .... ... 15
III. Ovarian and Oviduct Weights from Pre- and
Postovulatory Sceloporus cyanogenys, Series 2........ 16
IV. Liyer Weights and Total Plasma Proteins in
Female Sceloporus cyanogenys .........................  17
V. Quantitative Changes in Plasma Protein Fractions
in Sceloporus cyanogenys  ...........   18
VI. Adrenal Weight Changes in Female Sceloporus
cyanogenys .......    19
VII. Statistical Comparisons of Plasma Protein Fractions
(Compared to Control Start)  ...... ............. •••• 20
v
ABSTRACT
The influence of intrahypothalamic, intrapituitary and subcutaneous 
steroid implants on ovulation, ovarian growth and function were studied 
in Sceloporus cyanogenys. Implants of crystalline estrogen in the median 
eminence region of the hypothalamus were highly effective in inhibiting 
ovulation, but did not influence ovarian growth. Of the three estrogens 
tested, only estradiol 17 3 was 100% effective in ovulation inhibition.
In addition, implants of estradiol benzoate and estradiol undecylate in­
hibited ovarian steroid production, as indicated by oviduct growth. Sub­
cutaneous and intrapituitary implants of estradiol 17 3 did not influence 
ovulation, ovarian growth or function. Intrahypothalamic implants of 
progesterone inhibited ovarian growth and prevented ovulation in 50% of 
the experimental animals. Of animals implanted with cholesterol, only 
25% did not ovulate. No marked changes in liver.or adrenal weight that 
could be clearly correlated with the experimental treatment were observ­
ed. However, intrahypothalamic and intrapituitary estrogen depots sig­
nificantly increased total plasma protein due primarily to an increase 
in fraction number three.
THE INFLUENCE OF HYPOTHALAMIC STEROID IMPLANTS ON OVULATION 
AND OVARIAN GROWTH AND FUNCTION IN THE IGUANID LIZARD,
SCELOPORUS CYANOGENYS
INTRODUCTION
Evidence concerning the role of the hypothalamus in the control of 
the adenohypophysis has been summarized by Harris (1948, 1955). Since 
that time a large body of evidence relating to specific hypothalamic ar­
eas concerned with gonadal control has been revealed by lesion and hor­
mone implantation techniques in mammals. Lesions involving the median 
eminence result in not only anestrus but ovarian and uterine atrophy in 
guinea pigs (Dey et al., 1940; Dey, 1941, 1943), rats (D'Angelo, 1959; 
Cooke, 1959; Flerko and Bardos, 1959), cats (Laqueur et al., 1955), and 
in rabbits (Flerko, 1953). Lesions placed between the optic chiasm and 
the median eminence result in constant vaginal estrus and polyfollicular 
ovaries in the guinea pig (Dey et al., 1940; Dey, 1941, 1943). In addi­
tion, repeated periods of prolonged diestrus with hyperluteinized ovaries, 
occur in rats with dorsally placed lesions involving parts of the paraven­
tricular and dorso-medial nuclei (Flerko and Bardos, 1959). Hormone and 
ovarian autograft implantation experiments have revealed the importance 
of steroid sensitive units within the hypothalamus in gonadal feedback con­
trol (Flerko and Szentagothai, 1957; Holhweg and Daume, 1959; Lisk, 1960, 
1963).
Observations on'mammals have been extended to birds by Rothchild 
and Fraps (1949), Ralph and Fraps (1959, 1960), Assenmacher (1957 a, b, 
1958), and Kordon and Gogan (1964). Also Dierickx (1965, 1966, 1967)
3has indicated that the gonadotrophic center is present in the middle 
hypothalamus and that hypothalamic structures necessary for ovulation 
may be located in the pre-optic nucleus in the amphibian Rana temporaria.
A single report demonstrates the importance of specific hypothalamic 
areas for gonadal development in the goldfish (Peters, 1970).
In reptiles, a report by Lisk (1967) suggested the presence of 
steroid sensitive hypothalamic areas important in the onset of seasonal 
gonadal development in Dipsosaurus dorsalis, the desert iguana. No 
studies extending this observation have been made. The present experi­
ment is an attempt to clarify some of the interactions of gonadal ste­
roids with the hypothalamus in the control of ovarian growth and subsequent 
ovulation in the ovoviviparous lizard, Sceloporus cyanogenys.
MATERIALS AND METHODS
A. ANIMALS
Adult female Sceloporus cyanogenys, the ovoviviparous blue spiny 
lizard, were obtained in two groups from a commercial supplier in Texas 
during the month of December. Animals were housed in 20 sq. ft. enclo­
sures on a bedding of "Sanicel” (Paxton Processing Co.). Room tempera­
ture was maintained at 28° ± 2°C during the day and fell to 22° ± 2°C 
during the night. A 250 watt heat lamp was suspended at the edge of 
the pen which allowed a maximum of 37°C at the floor with a decreasing 
gradient across the pen. Shade was supplied and water was available 
ad libitum. Heat lamps and overhead fluorescent lights were automatically 
controlled on a 12 hour light - 12 hour dark regime. Animals were fed 
commercially supplied crickets daily.
The animals were divided into the following experimental groups for 
implantation of steroids:
Series 1 (Received and implanted early December)
A. Control start (autopsied on day 0).
B. Cholesterol intrahypothalamic implants.
C. Progesterone intrahypothalamic implants.
D. Estradiol 17 3 intrahypothalamic implants.
E. Estradiol 17 3 subcutaneous implants.
F. Estradiol 17 3 intrapituitary implants.
G. Sham pituitary implants.
5Series 2 (Received and implanted late December)
Twenty-three animals of this series were laparotomized at the start 
of the experiment to determine the extent of gonadal development. Four 
(17%) of these animals had ovulated and possessed developing embryos in 
the oviduct. Five of these animals were autopsied as beginning controls, 
3/5 being preovulatory.
A. Control start (autopsied on day 0).
B. Control end (autopsied on day 21).
C. Cholesterol intrahypothalamic implants.
D. Estradiol benzoate intrahypothalamic implants.
E. Estradiol undecylate intrahypothalamic implants.
The experimental period was 21 days with day 0 being the time of 
implantation.
B. HORMONAL IMPLANTS
Implants were prepared from 32 gauge stainless steel tubing dipped 
into the steroid heated to its melting point and stereotaxically placed 
according to Callard and Willard (1969). Quantities of steroid lodged 
in the tubes were estimated spectrophotometrically both prior to and fol­
lowing three weeks implantation as follows: 1) Before implantation:
Estradiol 17 3 24 ± 1.0 yg (n=10), progesterone - 39 ± 7.5 yg (n=8).
2) After implantation: Estradiol 17 3 12 ± 2.0 yg (n=8), progesterone -
11.8 ± 6.5 yg (n=7).
Subcutaneous implants were made by inserting a short piece of hor­
mone laden tubing through an incision in the lateral body epidermis.
6After three weeks implantation 15 ± 2.0 yg (n=5) steroid was found re­
maining in the tube. Implants of steroid in the adenohypophysis were 
made by exposing the gland ventrally through a hole made in the basisphe- 
noid with a dental pick. The steroid was implanted directly into the 
anterior lobe tissue and the hole in the basisphenoid plugged with Gel- 
foam (Upjohn Company). Sham pituitary implants were performed in the 
same manner, but no steroid was implanted in the gland.
At autopsy animals were killed by decapitation and the blood col­
lected in a heparinized centrifuge tube. Plasma was removed following 
centrifugation and frozen f6r later analysis. The liver, adrenals, thy­
roid, ovaries and oviducts were cleaned of adherant tissue and weighed. 
The numbers of ova and developing embryos were recorded. Heads were 
fixed in 10% formol and after 48 hours transferred to 20% ethanol and 
the brains removed. Gross localization of the probe in situ was made 
if possible. Whole brains were mounted in 5% gelatin, sectioned at 40 
microns in a cryostat and stained with thionin and subsequently examin­
ed microscopically for accurate localization of the implant placement. 
Serum proteins were separated on cellulose acetate strips and stained 
with oil red 0. After clearing the strips were scanned in a Gelman 
Model 39272 Scanner and quantified. Total plasma proteins were estimated 
using the Biuret reagent.
C. STATISTICAL METHODS
All data were analyzed using Studentfs t_ test with the exception 
of ovulation frequency (Table I) which was analyzed using confidence
7intervals for binomial proportions (Steel and Torrie, 1960). All data 
in the tables are given as means plus or minus the standard error (ex­
cept Table I).
The 5% level is the chosen level of significance. However, where 
a probability level above 5% occurs and there is reason to suspect bio­
logical significance the level is included in the text. A probability
✓
level of 1% is designated as highly significant.
Where pre- and postovulatory animals occurred in a single group 
(cholesterol, and estradiol 17 3 intrapituitary in series 1 and estra­
diol benzoate implanted animals in series 2) average values for total 
plasma proteins, liver and adrenal weights, were calculated for both 
pre- and postovulatory animals within each group. Since no significant 
differences were observed, these values were then combined to give a 
mean which included both pre- and postovulatory animals for these groups.
RESULTS
A. LOCATION OF IMPLANTS
All brain implants were located in the hypothalamus. Estrogen im­
plants ending in the median eminence region were most effective in in­
hibiting ovulation, a total of 14/15 of such animals being preovulatory. 
All estradiol 17 3 implants ended in the median eminence. Of the 5 
estradiol benzoate implanted animals which ovulated, one implant was in 
the lateral hypothalamus and another through the surface of the antero- 
medial region of the hypothalamus. Of the other three, one implant end­
ed in the median eminence, and two in the antero-medial hypothalamus.
Since 17% of the control animals of series 2 had ovulated, it is possible 
that these last 3 animals had ovulated prior to arrival in the laboratory. 
However, comparisons of the extent of embryonic development in pregnant 
animals were not made, and it is not possible to assess the validity of 
this possibility. In the estradiol undecylate group, one animal ovulated 
and the implant in this animal was through the surface of the antero- 
medial hypothalamus.
No attempt was made to recover estrogen implants from the adenohypo­
physis, although pituitaries were extirpated after fixation of the whole 
head.. Pituitaries from both sham-implanted and implanted animals were 
misshapen due to pressure exerted by the Gelfoam inserted to plug the 
hole in the floor of the skull.
9B * OVULATION, OVARIAN AND OVIDUCT WEIGHTS 
Series 1. (Tables I and II).
All starting controls were in the follicular growth stage. Three 
weeks after implantation ovulation occurred in 60% of the cholesterol 
group and 50% of the progesterone group. Animals with subcutaneous im­
plants of estradiol 17 3 all ovulated. In contrast, none of the animals 
with intrahypothalamic implants of estradiol 17 3 ovulated during the 
three weeks. The difference in ovulation frequency between animals with 
subcutaneous implants and beginning controls is significant, as is the 
difference between subcutaneous and" intrahypothalamic estrogen implants. 
Neither adenohypophyseal estradiol 17 3 implants nor the sham operation 
significantly affected ovulation frequency. #
Ovaries of animals arriving in the laboratory were in the growth 
phase. All animals receiving subcutaneous estradiol 17 3 implants ovu­
lated and hence the ovaries of these animals were quite small at autopsy 
consisting principally of corpora lutea (see Table II). Ovaries of pre­
ovulatory animals with implants of cholesterol and intrahypothalamic 
estradiol 17 3 were significantly larger than initial controls. Ovaries 
from progesterone implanted animals that did not ovulate were not sig­
nificantly different from initial controls, but were significantly small­
er than those of estrogen implanted animals.
Oviducts of start controls, estradiol 17 3 intrahypothalamic, and 
cholesterol implants that were preovulatory were similar in weight. 
Animals with estradiol 17 3 subcutaneous implants were all postovulatory
10
after three weeks. After intrahypothalamic steroid implantation, ovi­
ducts of postovulatory animals with cholesterol and progesterone implants 
were significantly smaller than those of animals with subcutaneous estra­
diol 17 3 implants. Ovarian and oviduct weights of postovulatory animals 
with adenohypophyseal estrogen depots were similar to those of other post- 
ovulatory animals. No meaningful comment regarding these parameters in 
the sham-operated animals can be made due to mortality in this group.
No differences in follicular numbers were observed. However, ani­
mals with subcutaneous estrogen implants had significantly smaller ovi- 
ducal eggs than either cholesterol or progesterone animals.
Series 2. (Tables I and III).
Three weeks after intrahypothalamic steroid implantation, 33% of 
the estradiol benzoate and 9% of the estradiol undecylate animals were 
postovulatory. In contrast, animals with cholesterol implants were 90% 
ovulated, and unoperated controls, 100%. The ovulation frequencies for 
estradiol undecylate treated animals were significantly lower than those 
for both the end controls and the cholesterol treated animals.
In this series, ovaries of start control preovulatory animals were 
significantly larger than those of start controls in series 1. At au­
topsy, ovaries of animals with estradiol benzoate and estradiol undecylate
i
implants that were not ovulated were not different from those of the start 
controls. Weights of postovulatory ovaries of all experimental groups 
showed a significant decline during the experimental period when compared
11
to the start controls.
Three weeks after steroid implantation, oviducts of preovulatory 
animals with estradiol benzoate and estradiol undecylate implants were 
significantly smaller than the beginning controls. In contrast, post­
ovulatory beginning controls had oviducts which were not different from 
postovulatory estradiol benzoate animals, cholesterol animals, or the 
three week controls. No differences in either follicular number or mean 
oviducal egg weight were observed.
C. LIVER WEIGHTS AND PLASMA PROTEINS (Tables IV and V)
Liver weights in series 1, of start controls and those with estra­
diol 17 3 intrapituitary implants are larger than those of all other 
experimental groups, both pre- and postovulatory. The difference is 
highly significant. Comparison of liver weights from hypothalamic es­
trogen implanted animals and those of subcutaneous estrogen implanted 
animals revealed a highly significant difference. However, liver weights 
of animals with estradiol implants in the hypothalamus are significantly 
larger than those of either the cholesterol or progesterone intrahypo­
thalamic groups (.1 <p > .05).
All animals in series 2 which were preovulatory have similar liver 
weights regardless of the treatment. As indicated by a comparison of 
beginning and final controls, or beginning controls and cholesterol im­
planted animals, liver weight decreased significantly following ovulation. 
This is further supported by the comparison of liver weights of pre- and 
postovulatory animals within the estradiol benzoate group where those of
12
preovulatory animals are significantly higher. Comparison of start 
control liver weights from series 1 and series 2 reveals that those 
of series 1 are significantly larger.
The total plasma protein of animals with either intrahypothalamic 
or intrapituitary estradiol 17 3 implants is higher than that for either 
starting controls, progesterone, or cholesterol implanted animals (p < 
.001 for.all three comparisons). Total plasma protein of animals with 
subcutaneous estrogen implants and intrahypothalamic progesterone im­
plants is similar to that for the starting controls. However, animals 
with cholesterol implants have a lower total plasma protein than the 
control animals.
In experimental series 2, although the estrogen implanted animals 
have, higher total plasma protein values than the start controls, the 
cholesterol treatment, or the end controls, no statistically signifi­
cant differences are observed. It is suggested, however, that this 
trend is biologically important since it parallels the effects in series 
1.
Quantitative examination of the plasma protein fractions (Table V) 
indicates that implantation of estradiol 17 3 in the hypothalamus causes 
a significant diminution in all protein fractions with the exception of 
fraction 3, (equivalent to mammalian alpha 2 globulin) which increases. 
Control, progesterone, and cholesterol treated animals are similar. In 
series 2 no marked quantitative changes in plasma protein fractions are 
observed. However, trends similar to those noted in series 1 are seen, 
particularly in fraction 3. No qualitative changes are noted in any
13
group, only 5 protein bands being observed.
D * ADRENAL WEIGHTS (Table VI)
Adrenal weights are highly variable. No significant differences 
are observed, except in series 2 where start controls are larger than 
all other groups.
14
TABLE I
THE INFLUENCE OF HORMONAL IMPLANTS ON OVULATION IN SCELOPORUS CYANOGENYS
Experimental Groups
Ovulation 
No, %
Confidence Interval 
(.95 Level)
Series 1
Control start 0/13 0.0 0.0 26.0
Cholesterol, IH 6/10 60.0 26.0 87.0
Progesterone, IH 5/10 50.0 18.0 82.0
Estradiol 17 3, IH 0/10 0.0 0.0 32.0
Estradiol 17 3* SC 5/5 100.0 63.0 100.0
Estradiol 17 3, IP 5/7 71.5 32.0 96.0
Sham Pituitary Implant 6/6 100.0 63.0 100.0
Series 2
Control start 4/23 17.0 5.0 37.0
Control end 5/5 100.0 • 63.0 100.0
Cholesterol, IH 9/10 90.0 47.0 100.0
Estradiol benzoate, IH 3/9 33.0 8.0 67.0
Estradiol undecylate, IH 1/11 9.0 0.0 40.0
EH = intrahypothalamic 
SC = subcutaneous 
EP = intrapituitary 
VT number ovulatedNO.= -----   ;----------- --
total m  treatment
OV
AR
IA
N 
AN
D 
OV
ID
UC
T 
WE
IG
HT
S 
FR
OM
 
PR
E-
 
AN
D 
PO
ST
OV
UL
AT
OR
Y 
SC
EL
OP
OR
US
 
CY
AN
OG
EN
YS
, 
SE
RI
ES
 
1
4-) 60
o
0  O
d  O
•H i—1
>
O  60
CO
rH
cd
B
•H
e
< 60
60 »
U W 60
O v_^
+-J Pi
cd cd •
rH a) 4J
5 a  xs.
o
+j
CO
o
Pm
60
o  
u  o  
cd t—i 
>
O  60
to
m
o
•
o
+i
o>
in
co
O
O
+1
cm
r^.
m
o
o
+i
CTi
m
vO
O
+1
CO
cn
CO CO
r H CM r H
O O O
• • •
o O o
+ 1 +1 +1
oo
rH
to
CO
o
+1
ov
co
CM
o
LO
o '
o
+i
00
CM
CM
o
o
+i
rH
CM
O
in
CM
CM
O
+1
vOMt-
CM
CO
CM
CM
OO
co
CM
60
OO
60
CO
rH
Cd
b
•rH
■§
uo
4 J
cd
co
CL) 
I—I ^o 
O -H 
Cd rH 
rH O Pi
60
& §
cd
>o 60
aa)
B■u
cd
a)uH
in in
r> 00 CO
c o rH O
c o O o CM
o
+1 +1 +1 +1 00
00 1—1 CO rH o
VO VO vo r^.• • .
■ c o o O
in in
CM rH m
i—1 CO o CM
+1 +1 +i orH
O r">• • •
co m CO
i—1 rH rH
in in
vO ov oo VO
vD ov O
c > O rH o CM< r
+1 +1 +1 +1 Ov
o \ CO r^. S3- CO
r> i—I CM CM 1—1• • •
vo o 00 rH
rH rH
CO rH o O m r^.
T— rH rH rH
cd' u Pm
H CO M
cd
M a A
M oa CQ CO.
+.) a
p A Q) r^.
cd rH Pi rH r- rH4- . O O
CO Pi Pi rH i— rH
0) 0) O c Or— 4-1 4-» •H •r •H
c CO CO d d d
V cd CD cd cd cd
■P rH 60 Pi p Pi
PI O O 4-1 ■ +- 4-1
c x: Pi CO CO COo o Pi W w W
CM
&
cd■u
•H
0 +J■w a
•H cd 
Ph rH 
PU 
S  B 
cd m  
XI 
C/3
o
• r l
B
cd
r H
Cd CO
XI 0
4-1 o
o a )
PU PS
cd
x: 4-)
cd C3
P i CJ
4-> X1
PS 0
• H CO
II II
c d o
M C/3 IP 
= 
in
tr
ap
it
ui
ta
ry
Su
pe
rs
cr
ip
t 
nu
mb
er
s 
re
pr
es
en
t 
ac
tu
al
 
’n
* 
wh
en
.g
ro
up
 
is 
sp
li
t 
in
to
 
pr
e-
 
an
d 
po
st
ov
ul
at
or
y 
an
im
al
s.
OV
AR
IA
N 
AN
D 
OV
ID
UG
T 
WE
IG
HT
S 
FR
OM
 
PR
E-
 
AN
D 
PO
ST
OV
UL
AT
OR
Y 
SC
EL
OP
OR
US
 
CY
AN
OG
EN
YS
, 
SE
RI
ES
 
2
COI—I
cd
e•H
ftO
4-J
cd
r—I
P
>O
4-J
COO
}-lo
4-J
cdi—i
P
>o<uu
CM
as in
OS CM 00o O O
4-1 60 /\l • • •
O o o o «—<
P O O n
M3 O o +1 +1 +1 CO
•H rH • •
> rH o o> CO O
O  60 ov CO Os
9 • •
O o o
CM cn in
CM l"s CM Ml-
O o O o
60 • « • •
60^-n o o O o
W  60'— ' +1 +1 +1 +1
C
cd • in m I'*
<U -M rH CM CM CM
a  xs • « • •o o O O
60
f t g
cd H  
>  \  
O  60
4-> 60O
P  O  
•X3 O  
•H i—I 
>o  co
CO
a)
rHO
•Hr—I i—I
Op4
60
OU o
Cd rH
K*
O  60
aQ)
e■u
cd
a)
H
rH
O o
Csl •o o
vO
Mf +1 +1
O ON oo CM
• •
o o
oo
CM
O
+1
vO
00
CO
o \
CM
+1
CO
CO
rH
o
+1
ON
OS
m
on
co
CM
vo
vo
«n
to 
I—t
o
+1
CM
CM
i—I 
rH
O
O
CO c—1
CM
O o
• •
O o
+1 +1
vOLQ m• •
O o
o
CO rH
00• •
tH o
+1 +1
• «
<r m
rH i—i
CD
CO rH
00 in00• •
o o
+1 +i
00 o
ON CO
• •
rH rH
rH rH
rH O
rH iH
#V
co
n 4-»
<D cd
4-> rH
cd tn
t u o a
M N 0)
4-J a M3
u A a> CJ
cd M3 rH rO p4-1 CJ O
CO 0) U rH rH
<D O O
rH »H 4-J •H •H
O O CO M3 M3
u U 0) cd cd
4-> 4~> rH M EC EC
a CJ O 4-J IH 4-J IH
o O -d CO CO
o O o W w
16
cd
o
CM
to
•sMl■H
p•H
n
EU
SC 
= 
su
bc
ut
an
eo
us
 
IP 
= 
in
tr
ap
it
ui
ta
ry
Su
pe
rs
cr
ip
t 
nu
mb
er
s 
re
pr
es
en
t 
ac
tu
al
 
’n
1 
wh
en
 
gr
ou
p 
is 
sp
li
t 
in
to
 
pr
e-
 
an
d 
po
st
ov
ul
at
or
y 
an
im
al
s.
17
TABLE IV
LIVER WEIGHTS AND TOTAL PLASMA PROTEINS IN FEMALE SCELOPORUS CYANOGENYS
Liver Plasma Protein
Treatment n (g/100 g) n (g/100 g)
Series 1
Control start 13 , 2.49 ± 0.08 7 5.46 ± 0.16
Cholesterol, IH 10 ' 1.65 ± 0.18 7 4.05 ± 0.19
Progesterone, IH 10 1.67 ± 0.23 9 4.93 ± 0.22
Estradiol 17 , IH 10 2.07 ± 0.10 9 7.04 ± 0.55
Estradiol 17 , SC 5 1.38 ± 0.09 4 5.95 ± 0.41
Estradiol 17 , IP 7 2.92 ± 0.27 5 9.37 ± 1.09
Sham Pituitary Implant 2 1.74 2 3.05
Series 2
Control start 5 1.81 + 0.21 3 4.08 + 0.59
Control end 5 1.00 + 0.04 4 4.34 + 0.65
Cholesterol, IH 10 1.25 + 0.11 8 4.14 + 0.20
Estradiol.benzoate, IH (Pre) 5 1.86 + 0.20 5 5.58 + 1.12
Estradiol benzoate, IH (Post) 5 1.18 ± 0.04 5 3.98 ± 0.28
Estradiol undecylate, IH 11 1.71 ± 0.12 11 5.18 ± 0.30
IH = intrahypothalamic 
SC = subcutaneous 
IP = intrapituitary
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TABLE VI
ADRENAL WEIGHT CHANGES IN FEMALE SCELOPORUS CYANOGENYS
Treatment n Body Wt. (g) Adrenal mg/100 g
Series 1
Control start 13 37.3 ± 3.4 11.26 ± 2.96
Cholesterol, IH 10 43.8 ± 1.2 10.97 ± 0.79
Progesterone, IH 9 57.7 ± 5.2 8.68 ± 1.58
Estradiol 17 3» IH 10 47.7 ± 2.5 10.03 ± 2.09
Estradiol 17 3, SC 5 29.6 ± 2.0 13.35 ± 3.02
Estradiol 17 3> IP 7 48.0 ± 4.7 7.75 ± 0.73
Sham Pituitary Implant 2 45.3 5.25
Series 2
\
Control start 4 46.3 ± 5.5 14.99 ± 2.18
Control end 5 49.7 ± 8.7 7.77 ±1.57
Cholesterol, IH 10 52.2 ± 4.1 8.50 ± 0.73
Estradiol benzoate, IH 11 48.8 ± 3.1 8.01 ± 0.68
Estradiol undecylate, IH 11 47.5 ± 2.6 10.84 ± 0.81
IH = intrahypothalamic 
SC = subcutaneous 
IP = intrapituitary
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DISCUSSION
In the first series of experiments, ovarian growth continued in 
the laboratory and was not influenced by estradiol implants. Ovaries 
of both cholesterol and progesterone implanted animals which did not 
ovulate are smaller than those of the estrogen implanted animals. Fur­
ther, gonads of progesterone implanted animals are not significantly 
larger than those of the controls. In contrast to the apparent absence 
of an effect on ovarian growth, intrahypothalamic estrogen had a pro­
nounced inhibitory effect on ovulation. In addition, both cholesterol 
and progesterone implants had some effect on ovulation frequency. Since 
none of the control animals had ovulated at the start of the experiment, 
and all but 2/18 of the other control groups (estradiol 17 8 subcutane­
ous, pituitary implants, and sham pituitary implants) ovulated before the 
end of the experimental period, the influence of intrahypothalamic estra­
diol on ovulation appears to be an important one. The argument that es­
trogen acts at the pituitary level (Bogdanove, 1963), carried to the 
adenohypophysis by the portal vessels, is dispelled to a certain extent 
by the relative ineffectiveness of estrogen implants into adenohypo- 
physeal tissue. However, it could still be argued that such implants 
are likely to be less effective than hypothalamic implants if one assumes 
that distribution of the hormone from the hypothalamus via the hypophy­
sial portal system is more effective than diffusion from the site of
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location in the anterior lobe. This assumption is difficult to verify, 
but it could be tested by using autoradiographic techniques.
Since subcutaneous implants were without effect on ovulation^a 
systemic (as opposed to intrahypothalamic) effect of the hormone on 
ovulation can be discounted. The amounts of hormone released from both 
subcutaneous and intrahypothalamic implants (about 17 yg/3 weeks or 
0.8 pg/day) are in fact quite large considering the potency of this 
hormone, if one uses mammalian criteria.
If follicular growth is dependent principally upon hypophyseal FSH 
and ovulation upon LH or a combination of FSH and LH, then it is diffi­
cult to escape the conclusion that the estrogen implants interfered with 
release of pituitary LH, but not FSH. However, in mammals, LH is in­
volved with steroid secretion by the gonad also (Chester Jones and Ball, 
1962). This activity appears to be unaffected in series 1 but inhibited 
in series 2, indicated by oviduct growth. It is possible that ovarian 
steroid production (estrogen perhaps) (Prisco et al., 1968) and concom­
itant ovarian growth in the lizard is dependent solely upon FSH and that 
LH is involved primarily with ovulation. It is also possible that pro­
lactin may be involved in ovarian steroid production (Callard and Zeigler, 
1970). Licht (1970) has suggested that there may be one gonadotrophic 
complex responsible for both ovarian growth and function. If so, ovarian 
growth, ovulation, and steroid production may require different titers of 
this gonadotropic complex.
The influence of cholesterol implants on ovulation in series 1 deserves
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comment. Since all but one of such animals in series 2 ovulated, the 
influence of cholesterol in the first group does not appear to be due to 
an effect on ovulation per se. It is possible, as with progesterone, 
that certain of these animals had a slower rate of follicular growth which 
prevented follicles from maturing to the size at which they would normally 
ovulate. The absence of preovulatory animals with ovarian weights in ex­
cess of 13.94 gm/100 gm, suggests that this weight is about the upper limit 
for egg size prior to ovulation. Preovulatory animals implanted with pro­
gesterone had smaller ova and therefore it is possible in this group that 
vitellogenesis (as expressed in ovarian growth) or ovarian uptake of vitel- 
logenic protein is diminished. Evidence from the literature indicates that 
progesterone can have a biphasic effect, either stimulating or inhibiting 
ovulation in the rat (Sawyer and Everett, 1959). Ralph and Fraps (1960) 
report that progesterone causes premature ovulation of the hen*s first 
follicle.
Data from the second series of experiments yielded essentially simi­
lar results. However, since ovaries of these animals upon arrival in the 
laboratory were already large and perhaps close to ovulation (17% of these 
animals had ovulated upon arrival) no influence of estrogen upon ovarian 
growth was seen. However, both estradiol benzoate and estradiol undecylate 
inhibited ovulation when implanted in the hypothalamus while cholesterol 
was ineffective. In contrast to series 1 animals, both groups of. estrogen 
implanted Sceloporus in the second series showed significant inhibition 
of oviducal growth. In fact, oviducts regressed. This result suggests
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an influence of estrogen implantation upon ovarian steroid production. 
These data may be reconciled with those of series 1 if one considers 
the smaller initial size of their oviducts. Further, estrogen implanted 
series 2 animals had oviducts more similar in weight to those of series 
1 than the controls of series 2. This result might suggest that the 
absence of an effect of estrogen upon oviducal growth in series 1 was 
due to the presence of relatively low titers of steroid which maintain­
ed a certain degree of oviduct development. However, further oviduct 
growth (seen in series 2) may require higher titers of estrogen which 
are not available in animals with estrogen implants.
Examination of implant locations revealed that median eminence im­
plants were most effective in inhibiting ovulation, only 1/16 animals 
ovulating when implants were in the median eminence. All estradiol 17 
$ implants were in the median eminence and, of the remaining animals 
(either estradiol benzoate or estradiol undecylate implants), only 6 
ovulated. Two of these had implants just through the antero-medial hypo­
thalamus, one implant was lateral to the median eminence and three ter­
minated in the antero-medial hypothalamus. Thus it appears that implants 
in the median eminence region and to a certain extent in the antero- 
medial hypothalamus are effective in ovulation inhibition. .These results 
suggest the importance of this region in the control of ovulation in 
lizards, as demonstrated in mammals and birds (Dey et al., 1940; D ’Angelo, 
1959; Flerko, 1953; Lisk, 1960, 1963; Kordon and Gogan, 1964; Ralph and 
Fraps, 1959). In Amphibia, Dierickx (1967) has suggested that the pre­
optic nucleus may contain structures necessary for ovulation. Previous
25
results from this laboratory (Callard and Willard, 1969; Callard and 
Chester Jones, 1970) have indicated the importance of this area of 
the lizard central nervous system in the control of the reptilian adre­
nal gland. In the lizard, Dipsosaurus dorsalis. one animal with an 
estradiol implant in the median eminence failed to show follicular de­
velopment (Lisk, 1967).
Relevant to any discussion of ovarian growth in reptiles is a 
consideration of vitellogenesis. Ovarian growth in reptiles and amphib­
ia principally dependent upon estrogen-induced hepatic synthesis of 
specific vitellogenic proteins (Hahn, et al., 1969 and Follett et al., 
1968) and gonadotropin-induced protein uptake by the gonad. It is 
known that this phenomenon is dependent upon ovarian estrogen production. 
Hepatic size in vitellogenic (preovulatory animals) was greatest in the 
beginning controls and decreased markedly in postovulatory controls in 
both series. Further, liver weights of the beginning controls of the 
first series were larger than those of the second, perhaps correlated 
with a decrease of active vitellogenesis in series 2 (animals in this 
group had maximally enlarged ovaries). Hypothalamic estrogen, choles­
terol, and progesterone implants appeared ineffective in influencing 
liver size; any differences in liver weights in implanted animals are 
probably due to a decrease in vitellogenesis. However, implants of 
estrogen in the pituitary may have increased liver weight.
Total protein levels are highest in animals with estradiol 17 8 
depots in the pituitary and hypothalamus. In animals with subcutaneous
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estrogen implants, total plasma protein is the same as that of initial 
controls. Examination of plasma protein fractions in series 1 reveals 
a marked effect of estradiol 17 3S increasing fraction 3 and decreas­
ing all others. A protein fraction with a similar electrophoretic mo­
bility increases following estrogen injection and during the ovarian 
growth phase in snakes (Dessauer and Fox, 1959). Although similar 
trends are noted in series 2 and are probably important, significant 
differences in total plasma protein were not detected.
This observation of an influence of intrahypothalamic and intra- 
pituitary estradiol 17 3 on the plasma protein picture is important 
when it is noted that subcutaneous estradiol 17 3 did not influence 
plasma proteins to a similar extent. However, the quantity of estra­
diol 17 3 released from the subcutaneous depot was sufficient to have 
a stimulatory effect upon the oviducts, whereas intrahypothalamic es­
trogen did not. These data suggest an action of estradiol at both 
hypothalamic and pituitary loci. Estrogen stimulates hepatic vitello­
genesis directly and the only report of hypophysectomy concludes that 
the hypophysis is not necessary for hepatic response to estrogen.
Relevant to the effects observed in these treatments are the 
differential effects of estradiol in series 1 and 2. There are at 
least two possibilities. First, the fact that estradiol 17 3 is a 
natural endogenous hormone, while estradiol benzoate and undecylate 
are synthetic esters, may explain the greater effect of estradiol 17 
3 on plasma protein levels. It is also a possibility that the dif­
ferential effects are a reflection of hepatic sensitivity changes
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dependent upon the stage of vitellogenesis. Since the series 2 animals 
were probably non-vitellogenetic at the time of steroid implantation, 
while those of series 1 were actively vitellogenic, estradiol benzoate 
and undecylate might be expected to have only a slight effect on the 
plasma proteins.
In summary, it is suggested that the effects of estradiol on both 
ovulation (inhibitory) and plasma protein levels (stimulatory) may be 
linked. If estrogen is the principal agent concerned with vitello­
genesis, either through a direct action on the liver or via the pitu-
}
itary-hypothalamic unit, or both, it may stimulate vitellogenesis 
while inhibiting ovulation. Such a dual action would allow ovarian 
growth to proceed without premature ovulation. The inhibitory effect 
of estradiol 17 3 implants on ovulation is consistent with mammalian 
findings. However, such implants in mammals also appear to inhibit 
ovarian growth and this effect was not seen in the lizard. On the 
contrary, the stimulatory effect of estradiol on plasma protein levels 
might suggest the opposite.
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